Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059420 · ClinicalTrials.gov registry record
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
A clinical trial of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT03059420: Recruiting study of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome, sponsored by Boston Children's Hospital.
NCT03059420 is a study of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 20,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03059420, a study of Congenital Fibrosis of Extraocular Muscles and Duane Retraction Syndrome, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
Primary Outcome
This is an observational, descriptive study with no interventions geared towards identifying novel genes and characterizing their function, expression and impact on human cranial nerve development and disease. As genes previously undescribed in the human population are identified and characterized, reports regarding these details will be written and published but such timelines are impossible to predict. Also, as new information on previously identified genes is gathered generated, additional re
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2004-02-01 |
| Est. Completion | 2030-01 |
What NCT03059420 shows while recruiting
NCT03059420 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 10 conditions, with Congenital Fibrosis of Extraocular Muscles appearing as the primary indexed condition, and to 0 interventions.
NCT03059420 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03059420 about?
NCT03059420 is a clinical study titled "Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies". The purpose of this study is to identify genes associated with impaired development and function of the cranial nerves and brainstem, which may result in misalignment of the eyes (strabismus) and related conditions.
What is the current status of trial NCT03059420?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2004-02-01. Estimated completion is 2030-01.
What conditions does trial NCT03059420 study?
This clinical trial studies the following conditions: Congenital Fibrosis of Extraocular Muscles, Duane Retraction Syndrome, Duane Radial Ray Syndrome, Mobius Syndrome, Brown Syndrome.
Who is sponsoring clinical trial NCT03059420?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03059420 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI